Protection Against Ischemia/Reperfusion Injury in Cardiac and Renal Transplantation with Carbon Monoxide, Biliverdin and Both

Both carbon monoxide (CO) and biliverdin, products of heme degradation by heme oxygenase, have been shown to attenuate ischemia/reperfusion (I/R) injury. We hypothesized in this study that dual‐treatment with CO and biliverdin would induce enhanced protective effects against cold I/R injury. Heterotopic heart and orthotopic kidney transplantation were performed in syngeneic Lewis rats after 24‐h cold preservation in UW solution. While monotherapy with CO (20 ppm) or biliverdin (50 mg/kg, ip) did not alter the survival of heart grafts, dual‐treatment increased survival to 80% from 0% in untreated recipients, with a significant decrease of myocardial injury and improved cardiac function. Similarly, dual‐treatment significantly improved glomerular filtration rates of renal grafts and prolonged recipient survival compared to untreated controls. I/R injury‐induced up‐regulation of pro‐inflammatory mediators (e.g. TNF‐α, iNOS) and extravasation of inflammatory infiltrates were significantly less with dual‐treatment than untreated controls. In addition, dual‐treatment was effective in decreasing lipid peroxidation and improving graft blood flow through the distinctive action of biliverdin and CO, respectively. The study shows that the addition of byproducts of heme degradation with different mechanisms of action provides enhanced protection against transplant‐associated cold I/R injury of heart and kidney grafts.

[1]  F. Bach,et al.  Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. , 2004, Gastroenterology.

[2]  O. Wagner,et al.  Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  P. Boekstegers,et al.  Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model. , 2004, Cardiovascular research.

[4]  G. Paradies,et al.  Decrease in Mitochondrial Complex I Activity in Ischemic/Reperfused Rat Heart: Involvement of Reactive Oxygen Species and Cardiolipin , 2004, Circulation research.

[5]  D. Stolz,et al.  Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. , 2003, The American journal of pathology.

[6]  H. Volk,et al.  Original Articles: Liver Biology and PathobiologyHeme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice☆ , 2003 .

[7]  H. Volk,et al.  Heme oxygenase‐1 and its reaction product, carbon monoxide, prevent inflammation‐related apoptotic liver damage in mice , 2003, Hepatology.

[8]  W. Baldwin,et al.  B Cell Deficiency Confers Protection from Renal Ischemia Reperfusion Injury 1 , 2003, The Journal of Immunology.

[9]  F. Bach,et al.  Heavy chain ferritin acts as an anti‐apoptotic gene that protects livers from ischemia‐reperfusion injury , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  A. Choi,et al.  Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility , 2003, Gut.

[11]  M. Suematsu,et al.  Bilirubin rinse: A simple protectant against the rat liver graft injury mimicking heme oxygenase–1 preconditioning , 2003, Hepatology.

[12]  Solomon H. Snyder,et al.  Biliverdin reductase: A major physiologic cytoprotectant , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Volk,et al.  Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1 , 2002, Transplantation.

[14]  H. Volk,et al.  Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. , 2002, Transplantation.

[15]  A. Batlle,et al.  Bilirubin: its role in cytoprotection against oxidative stress. , 2002, The international journal of biochemistry & cell biology.

[16]  K. Sönmez,et al.  Effect of bilirubin in ischemia/reperfusion injury on rat small intestine. , 2001, Journal of pediatric surgery.

[17]  R. Colvin,et al.  Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. , 2001, The Journal of clinical investigation.

[18]  F. Luft,et al.  Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function. , 2001, Kidney international.

[19]  J. Pearl,et al.  Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation. , 2001, The Annals of thoracic surgery.

[20]  B. Ke,et al.  Heme Oxygenase‐1 Overexpression Protects Rat Livers from Ischemia/Reperfusion Injury with Extended Cold Preservation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  D. Pinsky,et al.  Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis , 2001, Nature Medicine.

[22]  S. Norimizu,et al.  Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver. , 2001, Gastroenterology.

[23]  Thomas D. Schmittgen,et al.  Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. , 2000, Analytical biochemistry.

[24]  A. Choi,et al.  Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis , 2000, The Journal of experimental medicine.

[25]  B. Griffith,et al.  Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. , 2000, Circulation.

[26]  A. Choi,et al.  Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway , 2000, Nature Medicine.

[27]  P. Sarathchandra,et al.  Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. , 2000, American journal of physiology. Heart and circulatory physiology.

[28]  C. Vahl,et al.  Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model. , 1998, Cardiovascular research.

[29]  E. Verrier,et al.  Endothelial cell injury in cardiovascular surgery: ischemia-reperfusion. , 1996, The Annals of thoracic surgery.

[30]  R. Stocker,et al.  Bilirubin attenuates radical‐mediated damage to serum albumin , 1993, FEBS letters.

[31]  E. Bos,et al.  Malondialdehyde and glutathione production in isolated perfused human and rat hearts. , 1993, Circulation research.

[32]  Y. Yazaki,et al.  Expression of intercellular adhesion molecule-1 in rat heart with ischemia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. , 1993, The American journal of pathology.

[33]  J. Eaton,et al.  Ferritin: a cytoprotective antioxidant strategem of endothelium. , 1992, The Journal of biological chemistry.

[34]  B. Ames,et al.  Bilirubin is an antioxidant of possible physiological importance. , 1987, Science.

[35]  K Ono,et al.  Improved technique of heart transplantation in rats. , 1969, The Journal of thoracic and cardiovascular surgery.

[36]  Lee Sh,et al.  Microvascular surgical techniques in research, with special reference to renal transplantation in the rat , 1965 .

[37]  J. Cofer,et al.  The influence of preservation injury on rejection in the hepatic transplant recipient. , 1990, Transplantation.

[38]  S. Werns,et al.  Free radicals in ischemic myocardial injury. , 1985, Journal of Free Radicals in Biology & Medicine.